Discussion
People with immune-mediated thrombotic thrombocytopenic purpura (TTP) taking Cablivi (caplacizumab) plus immunosuppressants may need fewer therapeutic plasma exchange sessions than previously thought, a…
Thrombotic thrombocytopenic purpura is a rare, life-threatening blood disorder marked by dangerous clotting and low platelet counts. Prompt diagnosis and treatment are critical, and with proper care, most people recover and avoid serious complications.
While there’s no cure for immune thrombocytopenia, a range of treatments — from steroids to platelet-boosting therapies — can help manage symptoms. Choosing the right plan depends on platelet levels, bleeding risk, and individual health considerations.
Discussion
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsPeople with immune-mediated thrombotic thrombocytopenic purpura (TTP) taking Cablivi (caplacizumab) plus immunosuppressants may need fewer therapeutic plasma exchange sessions than previously thought, a…
Discussion
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsThe lack of a key enzyme in thrombotic thrombocytopenic purpura (TTP) may threaten fetal survival during pregnancy, according to a study involving rats. Researchers…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.